Toronto Dominion Bank Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Toronto Dominion Bank raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 202,571 shares of the medical equipment provider’s stock after purchasing an additional 21,079 shares during the period. Toronto Dominion Bank owned about 0.06% of Intuitive Surgical worth $105,734,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Carnegie Investment Counsel boosted its stake in Intuitive Surgical by 33.3% in the 4th quarter. Carnegie Investment Counsel now owns 653 shares of the medical equipment provider’s stock worth $341,000 after buying an additional 163 shares during the last quarter. Ritholtz Wealth Management boosted its position in shares of Intuitive Surgical by 1.0% in the fourth quarter. Ritholtz Wealth Management now owns 4,465 shares of the medical equipment provider’s stock worth $2,331,000 after acquiring an additional 44 shares during the last quarter. Occidental Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $296,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $36,000. Finally, Goldstone Financial Group LLC raised its stake in Intuitive Surgical by 7.1% during the fourth quarter. Goldstone Financial Group LLC now owns 513 shares of the medical equipment provider’s stock worth $268,000 after purchasing an additional 34 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $563.60 on Friday. Intuitive Surgical, Inc. has a 1 year low of $395.60 and a 1 year high of $616.00. The stock’s 50-day simple moving average is $505.22 and its 200-day simple moving average is $536.61. The firm has a market cap of $202.00 billion, a price-to-earnings ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the previous year, the business earned $1.50 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on ISRG shares. Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. CICC Research began coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective on the stock. Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. Finally, Raymond James lifted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 2,401 shares of the stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at $205,093. The trade was a 87.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,700 shares of company stock valued at $16,865,621 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.